Donna M Small Selected Research

Inflammation (Inflammations)

1/2022	Cathepsin S Contributes to Lung Inflammation in Acute Respiratory Distress Syndrome.
1/2021	Therapeutic Inhibition of Cathepsin S Reduces Inflammation and Mucus Plugging in Adult βENaC-Tg Mice.
1/2019	Targeting of cathepsin S reduces cystic fibrosis-like lung disease.
9/2015	Targeting Siglecs with a sialic acid-decorated nanoparticle abrogates inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Donna M Small Research Topics

Disease

5	Lung Diseases (Lung Disease) 01/2022 - 01/2015
4	Inflammation (Inflammations) 01/2022 - 09/2015
4	Pneumonia (Pneumonitis) 01/2022 - 01/2015
4	Neoplasms (Cancer) 12/2014 - 10/2009
3	Cystic Fibrosis (Mucoviscidosis) 01/2021 - 01/2015
3	Colorectal Neoplasms (Colorectal Cancer) 12/2014 - 10/2009
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022 - 02/2016
1	Neoplasm Metastasis (Metastasis) 12/2022
1	Colonic Neoplasms (Colon Cancer) 12/2022
1	Acute Lung Injury 01/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2021
1	Fibrosis (Cirrhosis) 01/2019
1	Persistent Infection 10/2018
1	Infections 10/2018
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2017
1	Radiation Fibrosis Syndrome (Radiation Fibrosis) 01/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017
1	Lung Injury 02/2016
1	Pseudomonas Infections 02/2016
1	Adenocarcinoma 10/2009

Drug/Important Bio-Agent (IBA)

5	cathepsin SIBA 01/2022 - 10/2009
3	Peptide Hydrolases (Proteases)FDA Link 01/2022 - 11/2013
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2015
3	Cysteine Proteases (Cysteine Protease)IBA 01/2022 - 10/2009
2	Death Domain ReceptorsIBA 12/2014 - 11/2011
2	AntibodiesIBA 12/2014 - 11/2011
1	Poly I-CIBA 12/2022
1	Salivary CystatinsIBA 01/2022
1	CathepsinsIBA 01/2022
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2022
1	MucinsIBA 01/2019
1	PAR-2 ReceptorIBA 01/2019
1	Collagen Type I (Type I Collagen)IBA 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2018
1	Gentamicins (Gentamicin)FDA LinkGeneric 10/2018
1	ceralasertibIBA 01/2017
1	Interleukin-17 (Interleukin 17)IBA 02/2016
1	Sialic Acid Binding Immunoglobulin-like LectinsIBA 09/2015
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 09/2015
1	ElafinIBA 01/2015
1	CamptothecinIBA 12/2014
1	Cell Surface ReceptorsIBA 12/2014
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 12/2014
1	Pharmaceutical PreparationsIBA 12/2014
1	PolymersIBA 12/2014
1	Caspase 8 (Caspase-8)IBA 12/2014
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 12/2014
1	conatumumabIBA 11/2011

Therapy/Procedure

1	Adjuvant Chemotherapy 12/2022
1	Radiotherapy 01/2017
1	Therapeutics 12/2014
1	Drug Therapy (Chemotherapy) 12/2014